What You’re Getting

This is a 9mg research blend of three distinct peptides: Sermorelin, GHRP-6, and GHRP-2. Think of it as a comprehensive toolkit for studying growth hormone secretagogue pathways in a controlled laboratory setting. Each component brings a different mechanism to the table, allowing for a more complete analysis of receptor interaction and signal integration than a single compound could provide. The vial in your hand is pure, research-grade material, synthesized and tested for accuracy. We don’t deal in guesswork.

Price: $96.80 | Ships same day if ordered by 12 PM PST.

Breaking Down the Components

Let’s talk specs. You need to know what you’re working with.

• Sermorelin (GRF 1-29): Molecular Formula: C149H246N44O42S | Molecular Weight: 3357.9 g/mol. This is a synthetic analogue of the first 29 amino acids of Growth Hormone-Releasing Hormone (GHRH). In research models, it specifically targets the GHRH receptor, primarily triggering the cAMP/PKA signaling pathway. It’s your key for studying the classic, primary release pathway.
• GHRP-6 (Growth Hormone-Releasing Peptide-6): Molecular Formula: C46H56N12O6 | Molecular Weight: 873.0 g/mol. A hexapeptide and a potent agonist of the GHS-R1a receptor (the ghrelin receptor). Its action is distinct from Sermorelin, primarily activating the phospholipase C (PLC) pathway, leading to inositol trisphosphate (IP3) formation and intracellular calcium mobilization. Research also notes its unique interaction with CD36 receptors, influencing appetite modulation studies.
• GHRP-2 (Pralmorelin): Molecular Formula: C45H55N9O6 | Molecular Weight: 818.0 g/mol. Another hexapeptide GHS-R1a agonist, but with a different structure than GHRP-6. This structural difference is crucial. Studies, such as those on ovine somatotrophs (Wu et al., 1996), show GHRP-2 can elevate intracellular cAMP levels similar to GHRH, while GHRP-6 does not. This makes the blend ideal for comparative research on ligand-specific signaling bias and receptor activation dynamics.

The Research Rationale: Why This Tri-Blend?

Using this blend in a lab model isn’t about just adding more of the same thing. It’s about investigating synergy and convergence. Sermorelin works through the GHRH receptor. GHRP-6 and GHRP-2 work through the GHS-R1a receptor. These are separate but communicating pathways.

When you introduce all three, your research can examine how these parallel signaling streams—cAMP from Sermorelin/GHRP-2 and PLC/calcium from GHRP-6/GHRP-2—integrate at the cellular level. Do they amplify each other? Are there feedback mechanisms that only become apparent with co-stimulation? Published in-vitro work (Yan et al., 2004) indicates that combined GHRH and GHRP-2 exposure can rapidly influence mRNA levels for GH, relevant transcription factors, and the receptors themselves, suggesting a coordinated genomic response.

Furthermore, having both GHRP-2 and GHRP-6 in the same blend allows for direct, controlled comparison of their effects within an identical experimental system. You can probe questions of receptor binding affinity, signal persistence, and desensitization kinetics between two closely related but functionally distinct secretagogues.

Potential Research Applications & Considerations

This blend is designed for rigorous, mechanistic research. Its applications are found in controlled preclinical studies focusing on:

• Receptor Crosstalk & Signal Integration: Studying how GHRH-R and GHS-R1a activation pathways converge in somatotroph or receptor-transfected cell models.
• Ligand-Specific Signaling Bias: Comparing the intracellular outcomes (cAMP, calcium flux, kinase activation) triggered by GHRP-2 versus GHRP-6 under identical conditions.
• Gene Expression Profiling: Investigating how combined receptor agonism affects the transcription of genes related to the somatotropic axis, as seen in prior in-vitro studies.
• Feedback Loop Analysis: Examining potential modulatory effects on related systems, including somatostatin receptor expression.

Critical Note: The additive effects observed in research are dose-dependent and system-dependent. Proper experimental design requires careful titration to understand the interaction profile. This is not a “more is better” scenario; it’s a “precision is everything” scenario.

Why Source This Blend From Peptide Pharmacy USA?

Because your research depends on the integrity of your materials. We get that. Here’s our offer:

• Uncompromised Purity: Every batch is independently verified by a third-party HPLC-MS lab. You get the certificate of analysis. What’s on the label is in the vial.
• Made in the USA: Our peptides are synthesized in a certified, sterile laboratory following strict cGMP guidelines. Supply chain control matters.
• No Gray Areas: We are a supplier to licensed researchers and institutions only. Our packaging is discrete, but our compliance is absolute. We verify credentials.
• <